Switzerland's Sandoz files antitrust lawsuit against Amgen in US
Tweet
Share
E-mail
The logo of Amgen and a robot miniature are seen in this illustration taken, July 17, 2023. REUTERS/Dado Ruvic/Illustration
(Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept).
(Reporting by Abinaya Vijayaraghavan; Editing by Rashmi Aich)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Motor racing-Milei puts himself in the driver's seat to bring F1 back to Argentina
- Canada to impose retaliatory tariffs on US steel, electronics, other products, Carney says
- India launches rescue operation as bulk carrier sinks off east coast
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
